Fundology

ETN / ETP · GraniteShares

3SAZ GraniteShares 3x Short Astrazeneca Daily ETP

ISIN XS2703639117London Stock Exchange: 3SAZGraniteShares Financial Plc

Latest close

LSE

£4.33

on

Fund size
£399k

As of , at least 15 min delayed

At a glance

As of 10/11/2026, 3SAZ (GraniteShares 3x Short Astrazeneca Daily ETP, ISIN XS2703639117) closed at £4.33 on the London Stock Exchange. Over the three years to 10/11/2026 its total return was −86.4%, or −87.7% after UK CPIH inflation.

Past returns

Total return: the change in the fund’s value with any income reinvested, after its ongoing charges. Periods to .
1 year to 10/11/2026
−49.1%
−50.9% after inflation
3 years to 10/11/2026
−86.4%
−87.7% after inflation

Volatility and the largest fall need a longer record of this fund’s prices than we hold so far. They appear on this page once we do.

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH

In plain English

GraniteShares 3x Short Astrazeneca Daily ETP is an exchange-traded product from GraniteShares, launched in 2019.

It aims to deliver a multiple, or the opposite, of one day’s move in what it tracks. The multiple resets daily, so over longer periods its return can differ a lot from the multiple of the index return.

You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.

Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Leveraged & inverse: Products that multiply or reverse a single day’s move — for example three times the daily change of an index.

Terms:Index fundAccumulating or incomeLeveraged ETPsShare classISIN

Key facts

Ticker
3SAZ
ISIN
XS2703639117
Tracks
Solactive Daily Leveraged 3x Short AstraZeneca Index - GBP
Structure
ETN / ETP
An exchange-traded note or product: a debt security that promises the return of an index. You also rely on the issuer.
Income
Accumulating
Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Fund size
£399k
Launched
Domicile
Ireland
UK reporting fund status
Yes — on HMRC’s list of reporting funds (list of )
Reporting fund since . What reporting fund status means
Can usually be held in
ISA and SIPP
Check with your platform: each decides which funds it offers.
Currency hedged
No
Price currency
Pounds (GBP)

Price chart

Closing price
£4.33−13.6% since 06/11/2026 · closing price
3SAZ closing price: £5.01 on 06/11/2026, £4.33 on 10/11/2026 (−13.6%); low £4.33, high £5.01.

Since 06/11/2026, the closing price went from £5.01 on 06/11/2026 to £4.33 on 10/11/2026 (−13.7%). The lowest close shown was £4.33 on 10/11/2026 and the highest £5.01 on 06/11/2026.

Closing prices we have recorded since 06/11/2026.

As of , at least 15 min delayed

Five years of prices, and after inflation

2 weekly closes, from 06/11/2026 to 10/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.

Create a free account to see the 5-year price chart and the after-inflation chart

Sign-up takes an email address. There is no card to enter and nothing to pay.

How we work it out:Prices and returnsNAV and price

Questions people ask

What does 3SAZ track?

3SAZ tracks the Solactive Daily Leveraged 3x Short AstraZeneca Index - GBP.

Is 3SAZ accumulating or distributing?

3SAZ is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

What is the ISIN of 3SAZ?

The ISIN of 3SAZ is XS2703639117. An ISIN identifies one exact share class of a fund; 3SAZ is its ticker on the London Stock Exchange.

How has 3SAZ done after inflation?

Over the three years to 10/11/2026 3SAZ’s total return was −86.4%, or −87.7% after UK CPIH inflation. Past performance is not a guide to future returns.

Similar funds

More leveraged and inverse products, largest first. Size is a fact, not a verdict.

Fund documents and methods

Methodology:ReturnsCategoriesAll methods

A machine-readable copy of this page: Markdown.